Fukatsu K, Saito H, Fukushima R, Inoue T, Lin M T, Inaba T, Muto T
Department of Surgery, University of Tokyo, Japan.
Arch Surg. 1995 Apr;130(4):410-4. doi: 10.1001/archsurg.1995.01430040072016.
To examine the effects of a nitric oxide synthase inhibitor on host elimination of bacteria, tumor necrosis factor (TNF) production, and survival in a murine sepsis model.
Prospective randomized experimental trials.
Laboratory.
Female Balb/c mice.
Balb/c mice were injected with Escherichia coli (10(8) colony-forming units per body) into the peritoneal cavity. N-omega-Nitro-L-arginine-methyl-ester (L-NAME), an inhibitor of nitric oxide synthase, was given intraperitoneally at 10 mg/kg (N10 group) or 100 mg/kg (N100 group) 1 hour before bacterial challenge.
Thirty animals were observed for survival. Samples of peritoneal lavaged fluid (PLF), blood, liver, and lungs were obtained at 4 and 6 hours after bacterial challenge (n = 60). The peritoneal exudative cells were counted. Viable bacterial counts were determined in PLF, blood, and organs. The TNF levels also were determined in plasma, PLF, and supernatant samples of cultured peritoneal exudative cells.
Survival times after E coli challenge were significantly reduced by pretreatment with L-NAME (100 mg/kg intraperitoneally). Numbers of viable bacteria in the peritoneal cavity and plasma TNF level 4 hours after E coli challenge were higher in both L-NAME-treated groups than in the control group. The number of bacteria in the blood and the plasma TNF level 6 hours after E coli challenge were higher in the L-NAME-treated group (N100 group) than in the control group. Conversely, the number of hepatic bacteria in the control group was significantly higher than in the L-NAME-treated groups. Plasma TNF level showed significant positive correlations with numbers of bacteria in the PLF and in the blood 4 hours after challenge. No significant differences were noted in TNF levels in PLF and peritoneal exudative cell cultured supernatants.
Inhibition of nitric oxide production is detrimental in this gram-negative sepsis model.
在小鼠脓毒症模型中,研究一氧化氮合酶抑制剂对宿主清除细菌、肿瘤坏死因子(TNF)产生及生存的影响。
前瞻性随机试验。
实验室。
雌性Balb/c小鼠。
向Balb/c小鼠腹腔内注射大肠杆菌(每只10⁸ 菌落形成单位)。在细菌攻击前1小时,腹腔注射一氧化氮合酶抑制剂N-ω-硝基-L-精氨酸甲酯(L-NAME),剂量为10 mg/kg(N10组)或100 mg/kg(N100组)。
观察30只动物的生存情况。在细菌攻击后4小时和6小时获取腹腔灌洗液(PLF)、血液、肝脏和肺的样本(n = 60)。对腹腔渗出细胞进行计数。测定PLF、血液和器官中的活菌数。还测定血浆中、PLF以及培养的腹腔渗出细胞上清液中的TNF水平。
腹腔注射L-NAME(100 mg/kg)预处理显著缩短了大肠杆菌攻击后的生存时间。在大肠杆菌攻击后4小时,两个L-NAME治疗组的腹腔内活菌数和血浆TNF水平均高于对照组。在大肠杆菌攻击后6小时,L-NAME治疗组(N100组)的血液中细菌数和血浆TNF水平高于对照组。相反,对照组肝脏中的细菌数显著高于L-NAME治疗组。攻击后4小时,血浆TNF水平与PLF和血液中的细菌数呈显著正相关。PLF和腹腔渗出细胞培养上清液中的TNF水平无显著差异。
在这种革兰阴性菌脓毒症模型中,抑制一氧化氮生成是有害的。